We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cabazitaxel in Platinum Refractory Ovarian Cancer

This study has been terminated.
(Too low inclusion rate. Only 4 patients included over 16 months)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01747239
First Posted: December 11, 2012
Last Update Posted: December 4, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Sanofi
Information provided by (Responsible Party):
Vejle Hospital
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: July 2014
  Primary Completion Date: July 2014 (Final data collection date for primary outcome measure)